Unknown

Dataset Information

0

Neurological consequences of COVID-19: what have we learned and where do we go from here?


ABSTRACT: The coronavirus disease-19 (COVID-19) pandemic is an unprecedented worldwide health crisis. COVID-19 is caused by SARS-CoV-2, a highly infectious pathogen that is genetically similar to SARS-CoV. Similar to other recent coronavirus outbreaks, including SARS and MERS, SARS-CoV-2 infected patients typically present with fever, dry cough, fatigue, and lower respiratory system dysfunction, including high rates of pneumonia and acute respiratory distress syndrome (ARDS); however, a rapidly accumulating set of clinical studies revealed atypical symptoms of COVID-19 that involve neurological signs, including headaches, anosmia, nausea, dysgeusia, damage to respiratory centers, and cerebral infarction. These unexpected findings may provide important clues regarding the pathological sequela of SARS-CoV-2 infection. Moreover, no efficacious therapies or vaccines are currently available, complicating the clinical management of COVID-19 patients and emphasizing the public health need for controlled, hypothesis-driven experimental studies to provide a framework for therapeutic development. In this mini-review, we summarize the current body of literature regarding the central nervous system (CNS) effects of SARS-CoV-2 and discuss several potential targets for therapeutic development to reduce neurological consequences in COVID-19 patients.

SUBMITTER: Jarrahi A 

PROVIDER: S-EPMC7525232 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9996554 | biostudies-literature
| S-EPMC7299026 | biostudies-literature
| S-EPMC8000735 | biostudies-literature
| S-EPMC9020580 | biostudies-literature
| S-EPMC9260036 | biostudies-literature
| S-EPMC4264300 | biostudies-literature
2020-12-11 | GSE163005 | GEO
| S-EPMC10034257 | biostudies-literature
| S-EPMC7271826 | biostudies-literature
| S-EPMC3438349 | biostudies-literature